Development of test systems for the discovery of selective human aldosterone synthase (CYP11B2) and 11beta-hydroxylase (CYP11B1) inhibitors. Discovery of a new lead compound for the therapy of congestive heart failure, myocardial fibrosis and hypert (Q44889550)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Development of test systems for the discovery of selective human aldosterone synthase (CYP11B2) and 11beta-hydroxylase (CYP11B1) inhibitors. Discovery of a new lead compound for the therapy of congestive heart failure, myocardial fibrosis and hypert |
scientific article |
Statements
1 reference
Development of test systems for the discovery of selective human aldosterone synthase (CYP11B2) and 11beta-hydroxylase (CYP11B1) inhibitors. Discovery of a new lead compound for the therapy of congestive heart failure, myocardial fibrosis and hypert (English)
1 reference
1 reference
Rita Bernhardt
1 reference
Katja Hübel
1 reference
Calin-Aurel Dragan
1 reference
Jochen Scher
1 reference
Hans Becker
1 reference
Natalie Lenz
1 reference
1 March 2004
1 reference
1 reference
217
1 reference
1-2
1 reference
249-254
1 reference
Identifiers
1 reference
1 reference